Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192


Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

Laidlaw BJ, Decman V, Ali MA, Abt MC, Wolf AI, Monticelli LA, Mozdzanowska K, Angelosanto JM, Artis D, Erikson J, Wherry EJ.

PLoS Pathog. 2013 Mar;9(3):e1003207. doi: 10.1371/journal.ppat.1003207. Epub 2013 Mar 14.


Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.

Sambhara S, Kurichh A, Miranda R, Tumpey T, Rowe T, Renshaw M, Arpino R, Tamane A, Kandil A, James O, Underdown B, Klein M, Katz J, Burt D.

Cell Immunol. 2001 Aug 1;211(2):143-53.


Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HL, van Run PR, Fouchier RA, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.

J Virol. 2016 Oct 28;90(22):10209-10219. Print 2016 Nov 15.


Immune responses to influenza virus infection.

Kreijtz JH, Fouchier RA, Rimmelzwaan GF.

Virus Res. 2011 Dec;162(1-2):19-30. doi: 10.1016/j.virusres.2011.09.022. Epub 2011 Sep 22. Review.


Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

Altenburg AF, Rimmelzwaan GF, de Vries RD.

Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Review.


Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.

Ding H, Tsai C, Zhou F, Buchy P, Deubel V, Zhou P.

PLoS One. 2011 Mar 25;6(3):e17821. doi: 10.1371/journal.pone.0017821.


Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.

Florek NW, Weinfurter JT, Jegaskanda S, Brewoo JN, Powell TD, Young GR, Das SC, Hatta M, Broman KW, Hungnes O, Dudman SG, Kawaoka Y, Kent SJ, Stinchcomb DT, Osorio JE, Friedrich TC.

J Virol. 2014 Nov;88(22):13418-28. doi: 10.1128/JVI.01219-14. Epub 2014 Sep 10.


Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.

Chua BY, Wong CY, Mifsud EJ, Edenborough KM, Sekiya T, Tan AC, Mercuri F, Rockman S, Chen W, Turner SJ, Doherty PC, Kelso A, Brown LE, Jackson DC.

MBio. 2015 Oct 27;6(6):e01024-15. doi: 10.1128/mBio.01024-15.


Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.

Wyrzucki A, Bianchi M, Kohler I, Steck M, Hangartner L.

J Virol. 2015 Mar;89(6):3136-44. doi: 10.1128/JVI.03069-14. Epub 2014 Dec 31.


A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.

Lee YN, Lee YT, Kim MC, Gewirtz AT, Kang SM.

J Immunol. 2016 Mar 15;196(6):2637-45. doi: 10.4049/jimmunol.1501637. Epub 2016 Feb 10.


Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.

Zhong W, Liu F, Dong L, Lu X, Hancock K, Reinherz EL, Katz JM, Sambhara S.

PLoS One. 2010 May 11;5(5):e10583. doi: 10.1371/journal.pone.0010583.


Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.

Wang Z, Kedzierski L, Nuessing S, Chua BY, QuiƱones-Parra SM, Huber VC, Jackson DC, Thomas PG, Kedzierska K.

J Gen Virol. 2016 Dec;97(12):3205-3214. doi: 10.1099/jgv.0.000651. Epub 2016 Nov 2.


Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.

Wang Z, Chua BY, Ramos JV, Parra SM, Fairmaid E, Brown LE, Jackson DC, Kedzierska K.

Vaccine. 2015 Sep 22;33(39):5148-54. doi: 10.1016/j.vaccine.2015.08.001. Epub 2015 Aug 13.


A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

Carragher DM, Kaminski DA, Moquin A, Hartson L, Randall TD.

J Immunol. 2008 Sep 15;181(6):4168-76.


Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.

Muramatsu M, Yoshida R, Miyamoto H, Tomabechi D, Kajihara M, Maruyama J, Kimura T, Manzoor R, Ito K, Takada A.

PLoS One. 2013 Aug 16;8(8):e71534. doi: 10.1371/journal.pone.0071534. eCollection 2013.


Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.

Hemann EA, Kang SM, Legge KL.

J Immunol. 2013 Sep 1;191(5):2486-94. doi: 10.4049/jimmunol.1300954. Epub 2013 Jul 24.


Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.

Bodewes R, Kreijtz JH, Hillaire ML, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2010 Jul;91(Pt 7):1743-53. doi: 10.1099/vir.0.020784-0. Epub 2010 Mar 24.


Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.

Yang S, Niu S, Guo Z, Yuan Y, Xue K, Liu S, Jin H.

Virol J. 2013 Sep 22;10:291. doi: 10.1186/1743-422X-10-291.


Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.

Budimir N, de Haan A, Meijerhof T, Gostick E, Price DA, Huckriede A, Wilschut J.

Influenza Other Respir Viruses. 2013 Nov;7(6):1202-9. doi: 10.1111/irv.12142. Epub 2013 Sep 16.

Supplemental Content

Support Center